Lytix calls in cash

Norwegian company Lytix Biopharma closes a USD 1.4 million funding round to finance new antimicrobial and oncology lead compounds.

Respiratorius hunts millions

The biopharmaceutical company Respiratorius has got a new CEO, who starts a public new share issue to catch almost SEK ten million.

Dako appoints new CEO

The Danish cancer therapeutic company Dako has appointed a new CEO after Patrik Dahlén.

Infidelity produces faster sperms

Until now, it has been difficult to prove that fast-swimming sperms have an advantage when it comes to fertilizing an egg.

Dupont gets new business manager

The Swedish API manufacturer Dupont Chemoswed has appointed a new business development manager.

Abbott expands by acquisition

An acquisition gives Abbott a leadership position in another large and growing medical device segment.

Swedish Medtech söker ekonom/jurist

Schizophrenia and bipolar disorder are relatives

Schizophrenia and bipolar disorder have the same genetic causes, according to a study from Karolinska Institutet.

LEO Pharma - International Clinical Trial Manager

Medicult disclaims Swedish offer

The Norwegian company Medicult's Board is highly sceptical to the yesterday announced Vitrolife offer.

Vitrolife wants to acquire Medicult

The Swedish company Vitrolife intends to make en exchange offer to the shareholders of the Danish company Medicult to acquire all outstanding shares in the company.

Medicult acquires embryo scanner

The Danish company Medicult signs an agreement with Novocellus to gain access to embryo selection technology.

New tools to fight bacteria

Better guidelines for doctors, detailed patient journals, and national monitoring systems are some of the tools needed to combat the increasing problem of antibiotic-resistant bacteria. That is stated in a report commissioned by the Swedish government.

Sales Representative, Applied Biosystems

A platform for dialogue

As a step towards connecting the life science industry in Denmark, Biologue was founded three years ago with 10 member companies. Today, the network has 40 members and a very busy event calender.

Time to save for survival

The future is bright for the biotech industry. However, the companies need to cut costs immediately if they want to survive the rough economic times.